Announcements

  • 'Impressed' FDA panel unanimously recommends GSK shingles vaccine

    By: Ben Dawes Ben Dawes , 8 years ago
    A U.S. Food and Drug Administration advisory panel on Wednesday voted 11-0 that the safety and efficacy of GlaxoSmithKline’s Shingrix shingles vaccine warrants approval for its use in adults aged 50 and over.